PRICE T ROWE ASSOCIATES INC /MD/ - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 1 filers reported holding IMMUNOMEDICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$113,689,000
-53.4%
1,337,049
-80.6%
0.01%
-58.1%
Q2 2020$243,813,000
+267.0%
6,879,606
+39.6%
0.03%
+181.8%
Q1 2020$66,441,000
-46.1%
4,928,823
-15.4%
0.01%
-31.2%
Q4 2019$123,320,000
+57.5%
5,827,991
-1.3%
0.02%
+45.5%
Q3 2019$78,304,000
-8.2%
5,905,279
-4.0%
0.01%
-8.3%
Q2 2019$85,312,000
-51.3%
6,150,864
-32.5%
0.01%
-53.8%
Q1 2019$175,009,000
-4.3%
9,110,330
-28.9%
0.03%
-16.1%
Q4 2018$182,870,000
-30.3%
12,815,023
+1.8%
0.03%
-18.4%
Q3 2018$262,221,000
+26.3%
12,588,635
+43.5%
0.04%
+18.8%
Q2 2018$207,582,000
+103.6%
8,769,819
+25.7%
0.03%
+100.0%
Q1 2018$101,970,000
-4.8%
6,979,461
+5.3%
0.02%
-5.9%
Q4 2017$107,103,000
+20.2%
6,627,662
+3.9%
0.02%
+13.3%
Q3 2017$89,138,000
+69.2%
6,376,132
+6.8%
0.02%
+66.7%
Q2 2017$52,695,000
+73.4%
5,967,762
+27.1%
0.01%
+50.0%
Q1 2017$30,382,000
+6476.2%
4,695,842
+3632.8%
0.01%
Q4 2016$462,000
+25.5%
125,800
+11.2%
0.00%
Q3 2016$368,000
+377.9%
113,100
+241.7%
0.00%
Q2 2016$77,000
-7.2%
33,1000.0%0.00%
Q1 2016$83,000
-18.6%
33,1000.0%0.00%
Q4 2015$102,000
+82.1%
33,100
+0.9%
0.00%
Q3 2015$56,000
-57.9%
32,8000.0%0.00%
Q2 2015$133,000
+5.6%
32,8000.0%0.00%
Q1 2015$126,000
-19.7%
32,8000.0%0.00%
Q4 2014$157,000
-1.3%
32,800
-23.4%
0.00%
Q3 2014$159,000
+1.9%
42,8000.0%0.00%
Q2 2014$156,000
+24.8%
42,800
+43.6%
0.00%
Q1 2014$125,000
-54.4%
29,800
-50.0%
0.00%
Q4 2013$274,000
+48.9%
59,600
+100.0%
0.00%
Q3 2013$184,000
-43.2%
29,800
-50.0%
0.00%
Q2 2013$324,00059,6000.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of IMMUNOMEDICS INC shareholders